
KUALA LUMPUR (Nov 28): Kotra Industries Bhd’s net profit declined 25% to RM13.66 million or 9.21 sen per share in its first quarter ended Sept 30, 2023 (1QFY2024), from RM18.24 million or 12.33 sen per share a year ago, in line with lower revenue.
Revenue dropped 18% to RM53.31 million from RM64.75 million in 1QFY2023, on weaker demand, said the pharmaceutical and healthcare products manufacturer in a bourse filing.
The group said there was an increase in demand for medication from the local market in the year-ago first quarter, with major shortages of various prescription items in the country.
Quarter-on-quarter, Kotra registered a decrease in revenue of 4.46% to RM53.31 million in 1QFY2024, compared with RM55.80 million in 4QFY2023, mainly due to decreased sales in the local market for both supplement and pharmaceutical products, partly offset by an increase in exports. Pre-tax profit, meanwhile, rose to RM13.90 million from RM13.49 million.
Kotra said the increase in net profit margin was mainly due to the product mix from sales, partially offset by the higher foreign exchange gain recorded in the preceding quarter.
Kotra’s shares closed one sen or 0.2% lower at RM5.02 on Tuesday, valuing the group at RM745 million.